PGS And 5 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) – PGS (PGS.OL), DNB BANK (DNB.OL), PROTECTOR FORSIKRG (PROT.OL) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. PGS (PGS.OL)

51.4% sales growth and 8.65% return on equity

Earnings Per Share

As for profitability, PGS has a trailing twelve months EPS of kr0.42.

PE Ratio

PGS has a trailing twelve months price to earnings ratio of 21.48. Meaning, the purchaser of the share is investing kr21.48 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.65%.

Sales Growth

PGS’s sales growth is 34.3% for the present quarter and 51.4% for the next.

Moving Average

PGS’s worth is above its 50-day moving average of kr8.52 and above its 200-day moving average of kr8.26.

Yearly Top and Bottom Value

PGS’s stock is valued at kr9.02 at 12:20 EST, way below its 52-week high of kr10.44 and way higher than its 52-week low of kr5.12.

More news about PGS.

2. DNB BANK (DNB.OL)

12% sales growth and 15.02% return on equity

DNB Bank ASA provides financial services for individual and business customers in Norway and internationally. The company offers savings, current, and pension accounts; fixed rate and security deposits; home and cabin mortgages, car and consumer loans, business loans, and refinancing; car, house, home contents, travel, personal, and non-life insurance product; payment services; and online and mobile banking services, as well as cards. It also provides overdraft facilities; leasing services; factoring, supply chain, and receivable purchase financing services; bank guarantee, secure trading, documentary collection, and letter of credit services; investment banking services, such as mergers and acquisition, equity and debt capital market, shares and securities, mutual funds and trading, and bonds and commodities; and private financing, as well as equity trading, foreign exchange, interest rates, and risk advisory services. In addition, the company offers treasury management, working capital, trade finance, auto lease and equipment financing, and corporate finance services, as well as act as an estate agents. DNB Bank ASA was founded in 1822 and is headquartered in Oslo, Norway.

Earnings Per Share

As for profitability, DNB BANK has a trailing twelve months EPS of kr25.78.

PE Ratio

DNB BANK has a trailing twelve months price to earnings ratio of 8.31. Meaning, the purchaser of the share is investing kr8.31 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.02%.

More news about DNB BANK.

3. PROTECTOR FORSIKRG (PROT.OL)

8.1% sales growth and 31.31% return on equity

Protector Forsikring ASA, operates as a non-life insurance company, provides various insurance products to the commercial and public sectors, and the grouped insurance schemes markets in Norway, Denmark, Sweden, the United Kingdom, and Finland. It operates in Commercial Lines of Business and Public Lines of Business segments. The company offers personal insurance, including personal and collective accident, critical illness, group life, health, and travel insurance; motor insurance; property insurance; and liability insurance. It sells its products through insurance brokers and agents. Protector Forsikring ASA was founded in 2003 and is headquartered in Oslo, Norway.

Earnings Per Share

As for profitability, PROTECTOR FORSIKRG has a trailing twelve months EPS of kr16.53.

PE Ratio

PROTECTOR FORSIKRG has a trailing twelve months price to earnings ratio of 14.52. Meaning, the purchaser of the share is investing kr14.52 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 31.31%.

Moving Average

PROTECTOR FORSIKRG’s value is higher than its 50-day moving average of kr227.53 and way above its 200-day moving average of kr217.85.

Yearly Top and Bottom Value

PROTECTOR FORSIKRG’s stock is valued at kr240.00 at 12:20 EST, under its 52-week high of kr265.00 and way higher than its 52-week low of kr160.00.

More news about PROTECTOR FORSIKRG.

4. DASSAULT SYSTEMES (DSY.PA)

6.9% sales growth and 14.34% return on equity

Dassault Systèmes SE provides software solutions and services worldwide. It offers SOLIDWORKS provides easy-to-use 2D and 3D product development solutions accessible to any business; CATIA, an engineering and design software for product 3D computer-aided design; GEOVIA for intersection of natural resources, infrastructure, and urban planning; and BIOVIA that develops chemicals, biologics, and materials experiences. The company provides SIMULIA that delivers realistic simulation applications; DELMIA, which enables global industrial operations; 3DVIA that provides 3D space planning solutions; and ENOVIA that enables to plan and track the definition of success for customer. In addition, it offers Centric PLM, a product lifecycle management software solution; 3DEXCITE, a real-time 3D visualization software; NETVIBES, which enables organizations to gather, align, and enrich big data; 3DEXPERIENCE platform that provides organizations a holistic and real-time view of their business activities and ecosystem, as well as connecting people, ideas, data, and solutions together in a single environment; and MEDIDATA, a clinical research study software that provides evidences and insights to pharmaceutical, biotech, medical device, and diagnostic companies, as well as academic researchers. The company distributes its products through direct and indirect sales channels. It primarily serves companies in the transportation and mobility; industrial equipment; aerospace and defense; high-tech; life sciences and healthcare; infrastructure, energy, and materials; home and lifestyle; architecture, engineering, and construction; cities, and public services; consumer packaged goods and retail; marine and offshore; and business services. Dassault Systèmes SE was incorporated in 1981 and is headquartered in Vélizy-Villacoublay, France.

Earnings Per Share

As for profitability, DASSAULT SYSTEMES has a trailing twelve months EPS of €0.79.

PE Ratio

DASSAULT SYSTEMES has a trailing twelve months price to earnings ratio of 51.95. Meaning, the purchaser of the share is investing €51.95 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.34%.

Sales Growth

DASSAULT SYSTEMES’s sales growth for the next quarter is 6.9%.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on May 27, 2024, the estimated forward annual dividend rate is 0.23 and the estimated forward annual dividend yield is 0.64%.

Yearly Top and Bottom Value

DASSAULT SYSTEMES’s stock is valued at €41.04 at 12:20 EST, way under its 52-week high of €48.88 and way above its 52-week low of €32.25.

Revenue Growth

Year-on-year quarterly revenue growth grew by 3.2%, now sitting on 6.06B for the twelve trailing months.

More news about DASSAULT SYSTEMES.

5. VISTIN PHARMA (VISTN.OL)

6.6% sales growth and 23.89% return on equity

Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. Vistin Pharma ASA was founded in 1969 and is headquartered in Oslo, Norway.

Earnings Per Share

As for profitability, VISTIN PHARMA has a trailing twelve months EPS of kr1.54.

PE Ratio

VISTIN PHARMA has a trailing twelve months price to earnings ratio of 17.34. Meaning, the purchaser of the share is investing kr17.34 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.89%.

Sales Growth

VISTIN PHARMA’s sales growth is 10.6% for the current quarter and 6.6% for the next.

Yearly Top and Bottom Value

VISTIN PHARMA’s stock is valued at kr26.70 at 12:20 EST, higher than its 52-week high of kr24.90.

More news about VISTIN PHARMA.

6. AXACTOR (ACR.OL)

5.2% sales growth and 9.72% return on equity

Axactor ASA, through its subsidiaries, operates as a debt management and collection company in Sweden, Finland, Germany, Italy, Norway, and Spain. It operates through two segments: Non-performing Loans and Third-Party Collection. The Non-performing Loans segment invests in portfolios of non-performing loans collected through amicable or legal proceedings. The Third-Party Collection segment provides debt collection services on behalf of third-party clients, which applies amicable and legal proceedings to collect the non-performing loans. This segment is also involved in helping creditors to prepare documentation for future legal proceedings against debtors; and handling of invoices between the invoice date and the default date and sending out reminders. Axactor ASA was incorporated in 1982 and is headquartered in Oslo, Norway.

Earnings Per Share

As for profitability, AXACTOR has a trailing twelve months EPS of kr0.77.

PE Ratio

AXACTOR has a trailing twelve months price to earnings ratio of 5.37. Meaning, the purchaser of the share is investing kr5.37 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.72%.

Moving Average

AXACTOR’s value is way below its 50-day moving average of kr5.43 and way below its 200-day moving average of kr5.94.

More news about AXACTOR.

Leave a Reply

Your email address will not be published. Required fields are marked *